NEW YORK (GenomeWeb) – Transgenomic said after the close of the market on Wednesday that it raised $2.375 million in gross proceeds from a private placement.

The financing was raised through a syndicate of new and existing institutional and other accredited investors, and funding will be used for general corporate and working capital purposes, including activities supporting Transgenomic's ICE COLD-PCR technology, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.